Neubauer BL - Search Results

1

Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of action.

Eisenberger MA, Laufer M, Vogelzang NJ, Sartor O, Thornton D, Neubauer BL, Sinibaldi V, Lieskovsky G, Carducci MA, Zahurak M, Raghavan D. Eisenberger MA, et al. Among authors: neubauer bl. Urology. 2004 Jan;63(1):114-9. doi: 10.1016/j.urology.2003.08.017. Urology. 2004. PMID: 14751361 Clinical Trial.

2

Androgen antagonists: Potential role in prostate cancer prevention.

Trump DL, Waldstreicher JA, Kolvenbag G, Wissel PS, Neubauer BL. Trump DL, et al. Among authors: neubauer bl. Urology. 2001 Apr;57(4 Suppl 1):64-7. doi: 10.1016/s0090-4295(00)00943-2. Urology. 2001. PMID: 11295597

3

Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the rat.

Neubauer BL, Bemis KG, Best KL, Goode RL, Hoover DM, Smith GF, Tanzer LR, Merriman RL. Neubauer BL, et al. J Urol. 1986 Jan;135(1):163-6. doi: 10.1016/s0022-5347(17)45554-6. J Urol. 1986. PMID: 3941458

4

Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984.

Neubauer BL, Merriman RL, Best KL, Goode RL, Sarosdy MF, Tanzer LR, Howbert JJ. Neubauer BL, et al. J Urol. 1992 Feb;147(2):500-4. doi: 10.1016/s0022-5347(17)37288-9. J Urol. 1992. PMID: 1732631

5

The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts.

Graff JR, McNulty AM, Hanna KR, Konicek BW, Lynch RL, Bailey SN, Banks C, Capen A, Goode R, Lewis JE, Sams L, Huss KL, Campbell RM, Iversen PW, Neubauer BL, Brown TJ, Musib L, Geeganage S, Thornton D. Graff JR, et al. Among authors: neubauer bl. Cancer Res. 2005 Aug 15;65(16):7462-9. doi: 10.1158/0008-5472.CAN-05-0071. Cancer Res. 2005. PMID: 16103100

6

Selective estrogen receptor modulators for the chemoprevention of prostate cancer.

Steiner MS, Raghow S, Neubauer BL. Steiner MS, et al. Among authors: neubauer bl. Urology. 2001 Apr;57(4 Suppl 1):68-72. doi: 10.1016/s0090-4295(00)00944-4. Urology. 2001. PMID: 11295598

7

Comparative effects and mechanisms of castration, estrogen anti-androgen, and anti-estrogen-induced regression of accessory sex organ epithelium and muscle.

Neubauer B, Blume C, Cricco R, Greiner J, Mawhinney M. Neubauer B, et al. Invest Urol. 1981 Jan;18(4):229-34. Invest Urol. 1981. PMID: 7451082

8

Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5alpha-reductase.

McNulty AM, Audia JE, Bemis KG, Goode RL, Rocco VP, Neubauer BL. McNulty AM, et al. Among authors: neubauer bl. J Steroid Biochem Mol Biol. 2000 Jan-Feb;72(1-2):13-21. doi: 10.1016/s0960-0760(99)00147-8. J Steroid Biochem Mol Biol. 2000. PMID: 10731633

9

Bradykinin-induced contractions of canine prostate and bladder: effect of angiotensin-converting enzyme inhibition.

Steidle CP, Cohen ML, Neubauer BL. Steidle CP, et al. Among authors: neubauer bl. J Urol. 1990 Aug;144(2 Pt 1):390-2. doi: 10.1016/s0022-5347(17)39467-3. J Urol. 1990. PMID: 2165184

10

Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells.

Kaefer M, Audia JE, Bruchovsky N, Goode RL, Hsiao KC, Leibovitch IY, Krushinski JH, Lee C, Steidle CP, Sutkowski DM, Neubauer BL. Kaefer M, et al. Among authors: neubauer bl. J Steroid Biochem Mol Biol. 1996 May;58(2):195-205. doi: 10.1016/0960-0760(96)00020-9. J Steroid Biochem Mol Biol. 1996. PMID: 8809201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters